July 2015 FDA Recall Sodium Chloride by Baxter Healthcare Corp.
D-1326-2015 - Presence of Particulate Matter and Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Baxter Healthcare Corp. on July 2, 2015 for the product Sodium Chloride. The FDA reported the reason for recall as presence of particulate matter and lack of assurance of sterility. The product was distributed in TX and TN and the recall is currently terminated.

Recall Number: D-1326-2015

Reason for Recall
Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors.
Initiated
07-02-2015
Reported
08-19-2015
Quantity
189,912 containers

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Baxter Healthcare Corp.
0.9% Sodium Chloride Injection USP, 500 mL in VIAFLEX Plastic Container, Baxter Healthcare Corporation Deerfield, IL 60015, NDC 0338-0049-03.

Batch or Lot Expiration Information

Lot# : C964601, Exp 4/30/2016